LES in Biological Technology

Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver

RALEIGH, N.C., Oct. 12 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that Ben Bonifant, Vice President of the firm's Business Development (BD) practice, will moderate two workshops at t...

ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canada's Ability to Deal with Biological Threats

...of IVT's DepoVax(TM) vaccine formulation to anthrax antigens to explore new methods to prevent, prepare for, and respond to biological threats. "Dr. les Nagata and his research team at DRDC are leaders in developing vaccines to fight deadly microbial pathogens and we look forward to this collaboration,...

FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD

...does not work properly. This valve opens to allow food and liquids to enter the stomach and closes to keep acid and food in the stomach. When the les does not close as tightly as it should, or relaxes too often, it can cause stomach contents to get into the esophagus repeatedly. The stomach is bette...

Japanese Cancer Association and Debiopharm Honour Japanese Research

...rd" designed to mentor and motivate young innovative European researchers in the field of life sciences, and in June, the "Prix Debiopharm Valais pour les Sciences de la Vie" aimed at encouraging entrepreneurship in the life sciences and technology sectors in the canton of Valais. About Debiopharm Grou...

Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.

...erim basis until a successor is appointed. A search will be undertaken to identify a successor. Dr. Mollica stated, "We appreciate the contributions les has made to the progress of the company since 2004 and wish him well. Pharmacopeia will build on its efforts in the development of pharmaceutical prod...

Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline

...llaboration model at GSK." "The exceptional productivity of the alliance so far reflects how well its goals fit with Pharmacopeia's strengths," said les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "We expect the excellent progress to continue as we focus on moving candidates t...

Pharmacopeia Announces Management Team Changes

... has facilitated the successful transformation of Pharmacopeia into a clinical stage development company by helping to build our broad pipeline," said les Browne, Ph.D., Pharmacopeia's President and Chief Executive Officer. "While we are saddened to see him leave his day-to-day position, we are very plea...

Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia

... commercialize Affymax's lead product candidate, Hematide(TM), for the treatment of anemia. The Affymax and Takeda collaboration was recognized by the les as one of the most notable deals in the healthcare industry sector in the last year. The 2007 Deal of Distinction Award recognizes worthy transaction...

Dane County mapping software updated, available to public

...lsen said, and property lines are updated monthly a figure the county would like to improve, but which is already much better than many systems. les Chappell contributed to this report ...

Wisconsin introduces new state IT plan

...le detail on whats going on and whats going to happen. - Mike Klein is WTNs editorial director and can be reached at mike@wistechnology.com . les Chappell, a staff writer for WTN, can be reached at les@wistechnology.com ....

Games that make leaders: top researchers on the rise of play in business and education

...s as good or bad, Gee said. It depends on what youre doing. Jason Stitt is WTN's associate editor and can be reached at jason@wistechnology.com . les Chappell is a staff writer and can be contacted at les@wistechnology.com ...

Measuring siRNA-mediated knockdown of IL-8 mRNA

...occurs when bDNA amplifiers bind the mRNA via the LEs. Signal amplification is precisely controlled by, and is directly proportional to, the number of les in the Probe Set, which is more reproducible than target amplification or PCR. As a result, the final luminescent readout is directly proportional to ...